Stock-Based Compensation |
9 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2024 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Equity [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock-Based Compensation |
Dalrada Financial Corp 2020 Stock Compensation Plan
On July 9, 2020, the Board authorized the Dalrada Financial Corp 2020 Stock Compensation Plan to be used to compensate the company board of directors. The plan allocates the issuance of up to 730,000, which is included in the Condensed Consolidated Statements of Operations and Comprehensive Loss. shares. On February 25, 2021, the Company amended the plan to issue up to shares and issued an aggregate of common shares, or 500,000 shares to each board member (9). shares of common stock were granted on July 9, 2020, at $0.08 per share and shares of common stock were granted on February 25, 2021, at $0.45 per share, for a total fair value of $
On May 10, 2021, the Company granted 430,027 which was calculated using the Black-Scholes model. options to purchase common stock to its Chief Financial Officer with an exercise price of $ per share. The options expire in ten years after issuance. The fair value of the options granted was $ per share, or $
On November 10, 2021, the Company cancelled shares issued to the Board of Directors and issued cashless warrants. cashless warrants were to vest immediately, and 2,000,000 cashless warrants were to vest over a 12-month period. All cashless warrants carry a $0.45 exercise price and a ten-year term. The Company recorded stock-based compensation related to the 6,500,000 shares in prior periods. The issuance of the warrants was treated as a modification and, as a result of the value of the stock-based compensation of the shares cancelled being greater than the stock-based compensation related to the cashless warrants issued, no additional stock-based compensation expense was recorded for the year ended June 30, 2022.
On November 30, 2021, the Company issued 0.45 per share. The cashless warrants expire in ten years after issuance. The fair value of the cashless warrants granted was $ per share, or $1,651,093 which was calculated using the Black-Scholes model. cashless warrants to employees and consultants for services performed. cashless warrants vested immediately and 1,450,000 cashless warrants vests over a 36-month period. The cashless warrants include an exercise price of $
On February 16, 2022, the Company issued 0.45 per share. The cashless warrants expire in ten years after issuance. The fair value of the cashless warrants granted was $ per share, or $1,338,644 which was calculated using the Black-Scholes model. cashless warrants to new members of the Board of Directors. The cashless warrants vest over a 12-month period and hold an exercise price of $
On August 11, 2022, the Company issued 0.45 per share. 450,000 cashless warrants vest over a 12-month period and hold an exercise price of $0.41 per share. cashless warrants vest over a 12-month period beginning April 8, 2023 and hold an exercise price of $0.45 per share. The cashless warrants expire in ten years after issuance. The fair value of the cashless warrants granted was $ per share, or $397,890 which was calculated using the Black-Scholes model. cashless warrants to new members of the Board of Directors and Advisors. cashless warrants vest over a 12-month period and hold an exercise price of $
On October 7, 2022, the Company issued 0.15 per share. The cashless warrants expire in ten years after issuance. The fair value of the cashless warrants granted was $ per share, or $5,101,223 which was calculated using the Fair Value method. The cashless warrants are contingent on the selling shareholder’s continued employment with the Company; therefore, it is treated as stock-based compensation expense and recognized ratably over a 24-month period. cashless warrants to the selling shareholder of Bothof in connection with acquisition of Bothof. The warrants vest over a 24-month period and hold an exercise price of $
On March 1, 2023, the Company issued 0.10 per share. The cashless warrants expire in ten years after issuance. The fair value of the cashless warrants granted was $ per share, or $68,975, which was calculated using the Fair Value method. cashless warrants to the selling shareholders of Dalrada Technology Ltd with the acquisition of Dalrada Technology Ltd. The warrants vest over a 36-month period and hold an exercise price of $
On April 14, 2023, the Company authorized and issued 0.45 per share. A total of cashless warrants vest over a 24-month period and hold an exercise price of $0.45 per share. A total of cashless warrants vest over a 36-month period and hold an exercise price of $0.33 per share. A total of cashless warrants vest over a 12-month period and hold an exercise price of $0.20 per share. A total of cashless warrants vest over a 12-month period and hold an exercise price of $0.12 per share. A total of cashless warrants vest over a 12-month period and hold an exercise price of $0.45 per share. A total of cashless warrants vest over a 12-month period and hold an exercise price of $0.09 per share. A total of cashless warrants vest over a 36-month period and hold an exercise price of $0.16 per share. A total of cashless warrants vest over a 36-month period and hold an exercise price of $0.25 per share. A total of cashless warrants vest over a 36-month period and hold an exercise price of $0.08 per share. The remaining cashless warrants vest over a 24-month period and hold an exercise price of $0.14 per share. The cashless warrants expire in ten years after issuance. The fair value of the cashless warrants granted was $ per share, or $2,143,402, which was calculated using the Black-Scholes model. cashless warrants to various officers, employees, and consultants of the Company. A total of cashless warrants vest over a 36-month period and hold an exercise price of $
On May 25, 2023, the Company authorized and issued 0.45 per share, and the remaining cashless warrants vest over a 36-month period and hold an exercise price of $0.08 per share. The cashless warrants expire in ten years after issuance. The fair value of the cashless warrants granted was $ per share, or $47,408, which was calculated using the Black-Scholes model. cashless warrants to various employees of the Company. A total of cashless warrants vest over a 36-month period and hold an exercise price of $
On September 6, 2023, the Company authorized and issued 0.10 per share. A total of cashless warrants vest over a 36-month period and hold an exercise price of $0.12 per share. A total of cashless warrants vest over a 36-month period and hold an exercise price of $0.17 per share. A total of cashless warrants vest over a 36-month period and hold an exercise price of $0.12 per share. The cashless warrants expire in ten years after issuance. The fair value of the cashless warrants granted was $ per share, or $2,064,699, which was calculated using the Black-Scholes model. cashless warrants to various officers, employees, and consultants of the Company. A total of cashless warrants vest over a 24-month period and hold an exercise price of $
On December 14, 2023, the Company authorized and issued 0.17 per share. The cashless warrants expire in ten years after issuance. The fair value of the cashless warrants granted was $0.17 per share, or $42,056, which was calculated using the Black-Scholes model. cashless warrants to various employees of the Company. All cashless warrants vest over a -month period and hold an exercise price of $
On January 30, 2024, the Company authorized and issued 0.20 per share. A total of cashless warrants vest over a -month period and hold an exercise price of $0.12 per share. A total of cashless warrants vest over a -month period and hold an exercise price of $0.20 per share. A total of cashless warrants vest over a -month period and hold an exercise price of $0.20 per share. cashless warrants to various employees and consultants of the company. A total of cashless warrants vest over a -month period and hold an exercise price of $
During the nine months ended March 31, 2024 and 2023, stock-based compensation was $ and $ , respectively. Total unrecognized compensation cost of non-vested warrants was $ on March 31, 2024, which will be recognized through fiscal year ending June 30, 2026.
|